Format

Send to

Choose Destination
Trends Endocrinol Metab. 2009 Sep;20(7):357-63. doi: 10.1016/j.tem.2009.03.009. Epub 2009 Aug 25.

Endocrine disruptors in female reproductive tract development and carcinogenesis.

Author information

1
Division of Dermatology, Department of Medicine and Department of Developmental Biology Washington University, St. Louis, MO 63110, USA. lima@dom.wustl.edu

Abstract

Growing concerns over endocrine disrupting chemicals (EDCs) and their effects on human fetal development and adult health have promoted research into the underlying molecular mechanisms of endocrine disruption. Gene targeting technology has allowed insight into the genetic pathways governing reproductive tract development and how exposure to EDCs during a critical developmental window can alter reproductive tract development, potentially forming the basis for adult diseases. This review primarily uses diethylstilbestrol (DES) as a model agent for EDCs and discusses the recent progress elucidating how DES and other EDCs affect murine female reproductive tract development and cancer at the molecular level.

PMID:
19709900
PMCID:
PMC2774851
DOI:
10.1016/j.tem.2009.03.009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center